Clinical Trial Update: Efficacy Study of Epoetin Alfa in Friedreich Ataxia [Phase 2]

View source ↗

Summary

Phase 2 efficacy study evaluating epoetin alfa in Friedreich Ataxia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Friedreich Ataxia

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)

Snippet

Sponsor: Federico II University | Conditions: Friedreich Ataxia | Phase 2 | Status: COMPLETED